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ABSTRACT
Objective: To evaluate the stage of maturation and the metabo-
lism of neurogenic heterotopic ossification by using SPECT/CT. 
Methods: A total of 12 medical records of patients with spinal 
cord injury, all of them classified according to the ASIA protocol 
(disability scale from the American Spinal Injury Association) in 
complete lesion (A) and partial lesions (B, C and D) and regis-
tered at the Laboratory of Biomechanics and Rehabilitation of 
the Locomotor System, were submitted to SPECT/CT evaluation. 
Results: Sixteen hips with heterotopic ossification observed in 
X-ray were studied and only two (12.5%) had high osteoblastic 
activity. Five hips showed medium activity, three (18.75%) low 
activity and six (37.5%) did not present any activity detected by 
SPECT/CT. Conclusion: SPECT/CT helps to determinate which 
patients have a greater risk of relapse after surgical resection, 
proving to be a useful imaging study  in preoperative evalua-
tion that can be used to determinate the postoperative prog-
nosis of these patients. Level of Evidence III, Investigating
a Diagnostic Test.




The term heterotopic ossification (HO), or myositis ossificans, 
is characterized by a process of abnormal osteogenesis in 
non-skeletal tissues, resulting from an initial inflammatory 
process. Such bone formations are not considered neoplas-
ms and can affect all types of soft tissues.1-4 In general, they 
originate from post-traumatic complications and may result in 
loss of range of motion and ankylosis in the more advanced 
stages of the disease, with serious damage to rehabilitation 
process.5,6 Being asymptomatic, HO is a major concern in 
the care of patients with spinal cord injury.7 Heterotopic ossi-
fication is considered a keyword to access to computerized 
databases worldwide. The term heterotopic calcification is 
related to other forms, non-orthopedic, of alterations by de-
position of calcium salts in soft tissues throughout the body.8 
The “myositis ossificans” nomenclature is used incorrectly, 
given that this is not a process restricted to muscles and 
often presents only mild inflamação.9 The origin of HO, its 
clinical presentation, location, and isolated or progressive oc-
currence shall define the type of ossification to occur, being 
classified into four types: 1. Post- traumatic (fractures, total 
hip arthroplasty or direct muscle trauma); 2. Neurogenic (spi-
nal cord injury or non-traumatic central nervous system in-
jury); 3. Myositis; 4.Progressive fibrodysplasia ossificans.10,11
The physiopathological analysis shows the need for the pre-
sence of three factors for the development of HO: osteogenic 
precursor cells, inducers and permissive environment. This 
combination allows the differentiation of mesenchymal cells 
into osteogenic cells.12 Several bone morphogenetic proteins 
are essential for mesenchymal cell differentiation into osteo-
genic cells, especially BMP-4. Under normal conditions, such 
a protein is subjected to a negative feedback due to anta-
gonists such as noggin, gremlin, chordin and follistatin. With 
reduced inhibitory response of these substances, BMP-4 is 
overexpressed by increasing the amount of osteogenic cells. 
This mechanism is responsible for the evolution of progressive 
fibrodysplasia ossificans. The most detailed and in-depth know-
ledge about its pathophysiology may significantly contribute to 
provide new perspectives in the treatment of neurogenic HO.13
The incidence of HO, found in the literature, varies between 
16% and 53%, becoming, however, especially high in patients 
exposed to a previous risk condition (such as spinal cord injury 
Article received in 08/20/2013, approved in 09/06/2013.
Acta Ortop Bras. 2014;22(1):12-6
13
and total hip arthroplasty). The discrepancy between these in-
cidence rates reported in the literature is due to several factors 
such as: the population studied, the duration of the studies, the 
methods used for data collection and the procedures adopted 
in each center.
In cases of neurogenic origin, the hips are the parts with the 
highest prevalence of HO, while the knees are less frequently 
affected.14 However, heterotopic ossification can occur in many 
parts in the body such as elbows, shoulders, fractures in gene-
ral or injuries in soft tissue.10
The primary method of HO classification was developed by 
Brooker et al.15 and it is based on anteroposterior radiographs 
of the pelvis, having originally been described for injuries oc-
curring after hip arthroplasty. (Chart 1)
Many authors have questioned the reliability and validity of this 
method.16 Therefore, other methods have been developed, as 
proposed by Della Valle et al.,17 a system composed of three 
steps: Grade A (hips without HO and hips with no ossification 
islands up to 1cm long – Brooker Grade I; Grade B (hips with 
at least one ossification island of over 1cm or pelvis with spurs 
in the hip or pelvis and at least 1 cm between opposing bone 
surfaces – Brooker Grade II , and Grade C (hip spurs and less 
than 1cm between femur and pelvis – Brooker Grade III - or 
ankylosis of the hip – Brooker Grade IV.
Besides from signs of inflammation in the acute phase of neu-
rogenic HO, other symptoms such as reduced range of motion 
and articular stiffness can be present.18,19 The differential diag-
nosis in the early stages include: deep vein thrombosis ( DVT), 
cellulitis, tumor calcinosis, variants of osteosarcoma, thrombo-
phlebitis, soft tissue tumors, hematomas and local trauma.20-23
The diagnosis of HO can be done through imaging, depending 
on the phase of the disease. Generally, to confirm the diagnosis 
and evaluation of the extent and metabolic activity of ossifying 
injury, conventional radiography is performed, followed by three-
-phase bone scintigraphy. It is also possible to use compute-
rized tomography.15,23 Laboratory tests may be performed to 
exclude other pathologies.
Currently, we rely on the development of hybrid technologies 
for a more appropriate image diagnostic. The single-photon 
emission computed tomography (SPECT), in combination with 
computed tomography multiple cuts (CT) allows the early de-
tection of subtle and non-specific abnormalities on bone scan 
and interpret them as focal pathology areas.24
SPECT/CT is the combination of both previously mentioned 
techniques. It uses a CT scanner associated with gamma 
cameras in a single structure. Collimators of different energy 
levels can be adopted according to the type of image to be 
generated. Processing occurs by the use of software able to 
mitigate and correct the data collected. Meanwhile, a resolu-
tion recovery algorithm is applied to correct the image blurs 
when a structure is a few inches from the colimador.24 The 
SPECT/CT method with the radiopharmaceutical methylene di-
phosphate labeled with technetium-99 metastable (MDP-99mTc) 
allows precise anatomic location of areas with osteoblastic 
activity by merging images of three-dimensional computed 
tomography scans with the same device, with the patient in 
the same position.
HO is a common complication in patients victim of spinal cord 
injury. The advances made in the study of its pathophysiology, 
rehabilitation and new types of treatment provide new hope 
for the treatment of this clinical condition.25 The ossification 
process can begin and be diagnosed early in the first weeks 
after trauma. It can often occur between the first four weeks, 
being more common during the second month after the injury, 
although it also occurs within one year after the accident.7
It can be difficult in some cases to correctly diagnose HO and 
it may often go unnoticed or be confused with cancer, fibro-
matosis, among others. Delays in the disease identification 
and erroneous conclusions can cause pain and suffering to 
patients and families at risk of aggravating the disease. It is very 
important to initially suspect of the diagnosis of HO from the first 
contact with the patient. Despite all limitations that can be found 
in various health services, these difficulties should not limit or 
delay the intervention once the diagnosis is primarily clinical.26
Currently, the most effective treatment is by surgical resection, 
which should occur when there is bone maturation (usually 6-9 
months after installation). However, this method has risks such 
as soft tissue injuries and recurrences and should be used only 
when there are restrictions on movement of the pelvis. Further-
more, resection may cause excessive bleeding, particularly in 
the femur, leading to increased morbidity and mortality. For this 
reason it is encouraged to search for new types of prophylaxis 
and establish the true therapeutic action of the chosen treat-
ment and its side effects, enabling decision making for certain 
types of prophylactic therapy or against its use.8
Prophylactic treatment can be done mainly by non-steroid anti-
-inflammatory drug (NSAID ) and radiotherapy. Its efficacy is 
controversial and there is no consensus about the only advan-
tage of radiotherapy. Several studies have been conducted 
regarding the use of prophylactic indomethacin, however, their 
effectiveness has not yet been attested.8
It is necessary to provide more opportunities for slowing the 
progression of HO in injured patients. This prevents onset and 
worsening of deformities in affected individuals as well as ena-
bling the establishment of prevention and treatment of HO, 
for what it is absolutely necessary the early diagnosis of the 
disease in the patient with spinal cord injury.
The association between the onset of HO and the appearance 
of patient comorbidities on injured spinal cord, such as auto-
nomic dysreflexia and DVT. This is an important complication 
due to its relationship with pulmonary thromboembolism (PTE) 
that can lead immediately to death. About one third of patients 
with PTE present symptoms of DVT in lower limbs.17 
Due to reduced range of motion, some cases may present with 
ankylosis of the pelvis joint, contributing thus, to venous stasis 
in the lower limbs, therefore predisposing to DVT and pressure 
ulcers. It is described that the physiopathogenesis of DVT in 
Chart 1. Classification proposed by Brooker et al.15 according to ra-
diologic aspects of injury.
Grade I Ossification islands around the hip 
Grade II
Bone projection of pelvis or proximal femur with at least 1 cm 
away from the opposite surface 
Grade III
Bone projection of pelvis or proximal femur reducing space 
between opposite surface lower than 1 cm 
Grade IV Hip ankylosis
Acta Ortop Bras. 2014;22(1):12-6
14
HO is not only related to vascular stasis triggered by the mass 
effect of HO, but also to an inflammatory mechanism.6
Therefore, it is essential to early and active pursuit HO, in order 
to identify patients at higher risk for these related comorbidities, 
which also enable the development of prevention projects that 
lessened the morbidity and mortality of patients with spinal 
cord injury.
The use of SPECT/CT enables a precise anatomical diagno-
sis of HO, being superior to other imaging methods, such as 
radiography and computed tomography. Moreover, SPEC/CT 
is able to determine the maturation of HO, showing whether 
resection would be safe.
This study aims to evaluate and classify the maturity and 
bone metabolism in neurogenic heterotopic ossification in 
patients with spinal cord injury using SPECT/CT examination 
with MDP-99mTc as radiopharmaceutical that measures osteo-
blastic activity, because it integrates with the bone matrix to 
mimic phosphate by osteoblasts.
The main objective of this study is to evaluate the stage of matu-
ration and metabolism of neurogenic heterotopic ossification by 
SPECT/CT examination, defined establishing the status of injury. 
To perform the study, the maturity status of each respective 
newly formed bone was related to Brooker classification chart.
MATERIALS AND METHODS
This study analyzes the results from SPECT/CT in patients with 
paraplegia and tetraplegia. The process aggregated patients of 
Hospital de Clinicas (HC), Universidade Estadual de Campinas 
(Unicamp), SP, Brasil.
This research project was approved by the Local Ethics Com-
mittee of the Faculdade de Ciências Médicas (FCM), Unicamp. 
All patients that underwent SPECT/CT were aware of the risks 
inherent to the exam and signed an informed consent term rou-
tinely used by the Serviço de Medicina Nuclear, HC (Unicamp).
For this study, medical records of 12 patients with spinal cord in-
jury at Hospital das Clínicas, Unicamp, were used, all cataloged 
from the ASIA protocol (deficiency scale of the American Spinal 
Injury Association) in complete lesion (A) or Incomplete (B, C, 
D), that have been treated at the Laboratory of Biomechanics 
and Rehabilitation of the Locomotor System.
Once the choice of patients for the study was completed, all 
of them were duly informed and agreed to be included in the 
study, signing an informed consent form.
For SPECT/CT examination, participants provided some preli-
minary information to draw a profile of each patient, such as:
•	 Gender (male or female)
•	 Age; injury level;
•	 Asia;
•	 Cause of the injury;
•	 Injury time;
•	 The data having been shown in a chart.
Thus, patients were directed to SPECT/CT examination, a pro-
cedure performed by Serviço de Medicina Nuclear, HC, Uni-
camp, appliance Symbia T SPECT/CT Siemens where they re-
ceived 1110 Megabecquerels (Mbq) of MDP99mTc intravenously. 
Planar imaging of blood flow (images every 2 seconds for 80 
seconds) and balance (static image with 500,000 counts, matrix 
256x256 pixels) of the pelvis immediately after, and 3 hours after 
injection, performed whole-body scans in anterior and poste-
rior projections, with a 12 cm/min speed, static images and 
SPECT/CT (with detectors in 360° configuration, 20 seconds 
per projection, 60 projections per detector), pelvis and other 
areas of interest. The planar images were recorded partly in a 
Millennium MG gamma camera from General Electric, with the 
same parameters, according to the service logistics.
Inclusion Criteria
1. Patients para/tetraplegic with an established diagnosis of 
HO spinal cord after injury, i.e., upper motor neuron lesion 
with levels above T12.
2. The development of HO should be secondary to spinal cord 
injury, and the patient should have not suffered mechanical 
trauma in the site where HO developed. This, thus, excludes 
the traumatic factor from triggering the process.
3. Patients with lesion for over one year.
The results from SPECT/CT were verified from the respective 
radioisotope uptake assuming that, in the region where there 
is more uptake of radioisotope, there will be more osteoblastic 
activity, featuring the lesion areas of heterotopic ossification 
activity. Conversely, areas of heterotopic ossification with little 
radioactivity uptake characterize mature lesions. Furthermore, 
the result of Brooker classification was also considered as an 
important relationship since, from this analysis, it is possible to 
identify the likely progression of HO from grade II to grade III, 
for example, by reducing or even preventing ankylosis of joints 
and surgical procedures.
For this study, there were established statistics to illustrate the 
most common sites affected by HO, as well as patient’s age, 
and ASIA classification.
All data collected were grouped into a spreadsheet in Microsoft 
Excel 2010 and were forwarded to statistical analysis.
RESULTS
Of the 12 patients (16 pelves) who had heterotopic ossification 
in the hip and participated in the study, all were male, aged 
between 25 and 59 years, with a mean age of 39 years.
The level of spinal cord injury in these patients occurred be-
tween C4 to T8, being 63.7% in the thoracic spine and 36.3% 
in the cervical spine. (Figure 1)
Among the patients studied, 11 (90.9%) were classified as ASIA 
A, and only one patient (9.1%) was classified as ASIA B. (Figure 2)
Figure 1. Level of spinal cord injury.
Thoracic spine
Cervical spine
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The causes of spinal cord injury were motorcycle accidents 
(72.8%), injury by firearms (18.2%) and fall from heights 
(9%). (Figure 3)
The time of spinal cord injury ranged from 3-18 years, where 
45.5% had spinal cord injury for less than ten years.
Of the 16 pelves studied that showed heterotopic ossification 
at the X-Ray, only two (12.5%) showed marked osteoblastic 
activity. Five pelves (31.25%) showed moderate activity; three 
(18.75%) mild activity; and six hips (37.5%) showed absence of 
osteoblastic activity in the SPECT/CT exam. (Figure 4)
DISCUSSION
Figure 5. Pelvis radiography showing heterotopic ossification in both hips.















Figure 2. Classification of spinal cord injury.
Heterotopic ossification is a complication possibly observed in 
patients with spinal cord lesions.7 It can affect any joint, most 
commonly the hip. (Figure 5) It can limit the range of motion 
hampering, thus, the rehabilitation of these patients, since it 
undermines the position change, bed transfer and placement in 
the sitting position.1 Preventing these disease with anti-inflam-
matory drugs such as indomethacin and radiotherapy are con-
troversial in the literature and still have their role questionable, 
which requires new and more detailed studies to establish the 
use of such measures as indisputable tools on HO prevention.8 
In this scenario, the use of surgical resection remains as the 
treatment of choice since HO is established, remembering, 
however, that the surgical treatment of this entity is associated 
with intense intra-operative bleeding and high rates of relapse.21
It is believed that relapse is associated with the presence of 
osteoblastic activity in the HO focus at the time of resection. In 
other words, remaining osteoblastic cells would be responsible 
for recurrence, similarly to what happens with an incomplete 
resection of a neoplasm. This fact leads some authors to con-
sider one HO a pseudotumoral injury.
This study was performed using SPECT/CT to determine os-
teoblastic activity in patients with spinal cord injury presenting 
with HO. (Figure 6) The uptake was ranked as: absent, mild, 
moderate, and severe. In the sample used, none of the patients 
underwent resection, because they had a functional range of 
motion. However, it is believed that the degree of uptake is 
probably related to the risk of relapse of the resected lesions, 
because the higher the activity, the more osteoblasts producing 
bone matrix will be present.
Analyzing the results obtained, it can be said that not all hips 
with HO show higher osteoblastic activity. Furthermore, no di-
rect relationship between time and level of spinal cord injury 
and the degree of maturation of HO in SPECT/CT was found.
However, we cannot say that the absence of scintigraphic up-
take in the focus of HO will ensure resection without relapse. 
(Figure 7) Eventually, latent osteoblasts can be reactivated by 
inflammation due to the surgical aggression. Therefore, radio-
therapy is widely used postoperatively in order to destroy the 
remaining or latent osteoblasts, reducing relapse rates.18
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CONCLUSION
HO is a detrimental clinical condition to rehabilitation and care of 
patients with spinal cord injury, hindering their social interaction.
SPECT/CT helps to determine which patients shall present hi-
gher risk of relapse after resection, showing to be a good test 
in the preoperative evaluation. A study in patients with indication 
for resection and previous SPECT/CT exam can corroborate 
the results of this study, making this test a valuable resource 
to determine the postoperative prognosis.
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Figure 6. CT scan images (A) and the same images added to bone scin-
tigraphy (B), showing moderate captation in both heterotopic ossifications 
(same patient as from Figure 5).
Figure 7. Scintigraphy images (A), CT scan images (B) and SPECT/CT 
images showing heterotopic ossification (C) without increase of radio-
pharmaceuticals intake.
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